Clinical trials
Obesity, Morbid clinical trials
Below are recruiting obesity, morbid clinical trials, each written for real people, not researchers. We’re tracking 102 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03497143Recruiting
Gastric bypass or sleeve surgery and lamotrigine drug levels
This study measures how well lamotrigine (a seizure/mood-stabilizing medicine) is absorbed after planned weight-loss surgery. It may help doctors understand whether medicine doses need adjustment after bypass or sleeve surgery.
TrondheimAges 18–70 - NCT03460327Recruiting
Study of candesartan blood levels around weight-loss surgery
This trial measures how the blood pressure medicine candesartan is absorbed in your body before and after gastric bypass or sleeve gastrectomy. It may help doctors predict the right dosing for people taking this medication after bariatric surgery.
TrondheimAges 18–70 - NCT02939664Enrolling by invitation
Laparoscopic gastric bypass vs banding for weight loss
This trial compares two types of minimally invasive weight-loss surgery: gastric bypass versus a gastric band. It looks at which approach works better and is safer for people who qualify for bariatric surgery and have not succeeded with supervised weight-loss programs.
Majadahonda, MadridAges 18–65 - NCT02024542Recruiting
How the body changes after bariatric surgery
This study looks at how metabolism (how your body handles food and energy) responds after weight-loss surgery. It may help researchers understand what changes to expect in people with diabetes or prediabetes and cholesterol problems.
Sacramento, CaliforniaAges 18–55 - NCT01055054Enrolling by invitation
Bariatric surgery registry for people with severe weight gain
This study is a registry, meaning it collects health information to better understand outcomes after bariatric (weight-loss) surgery. It may help doctors improve care for people with severe obesity who had surgery at VCU Medical Center.
Richmond, VirginiaAges 12–75 - NCT05802121RecruitingEarly Phase 1
Testing a gut bacteria supplement side effects during prostate hormone therapy
This early-phase study looks at how changing gut bacteria (especially Akkermansia) affects metabolic side effects in men starting prostate hormone therapy (ADT). It may help researchers understand how to reduce or manage side effects for people on ADT.
London, OntarioAges 18 years+
Hear when a new Obesity, Morbid trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for obesity, morbid?
- Yes. Clin2 currently lists 102 recruiting obesity, morbid studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a obesity, morbid trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a obesity, morbid trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.